OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Screening Techniques for Drug Discovery in Alzheimer’s Disease
Sandra Maniam, Subashani Maniam
ACS Omega (2024) Vol. 9, Iss. 6, pp. 6059-6073
Open Access | Times Cited: 12

Showing 12 citing articles:

Perturbations in the neuroactive ligand-receptor interaction and renin angiotensin system pathways are associated with cancer-related cognitive impairment
Raymond J. Chan, Adam K. Walker, Janette Vardy, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 4
Open Access | Times Cited: 1

Emerging biophysical techniques for probing synaptic transmission in neurodegenerative disorders
Mayur B. Kale, Nitu L. Wankhede, Ashok Kumar Bishoyi, et al.
Neuroscience (2024) Vol. 565, pp. 63-79
Closed Access | Times Cited: 6

Sulfonic acid functionalized β-amyloid peptide aggregation inhibitors and antioxidant agents for the treatment of Alzheimer's disease: Combining machine learning, computational, in vitro and in vivo approaches
Vinit Raj, Chaitany Jayprakash Raorane, Divya Shastri, et al.
International Journal of Biological Macromolecules (2025), pp. 140142-140142
Closed Access

Protective Effects of Ginkgolide A Against Hydrogen Peroxide-Induced Oxidative Damage in Neuronal Cells and Its Mechanisms
Pengju Ma, Xiao Shao, Qing He, et al.
Revista Brasileira de Farmacognosia (2025)
Closed Access

Design and development of chromene-3-carboxylate derivatives as antidiabetic agents: Exploring the antidiabetic potential via dual inhibition of Angiotensin II Type 1 Receptor and Neprilysin enzyme
Shikha Thakur, Sandhya Chahal, Madhav S Jadhav, et al.
European Journal of Medicinal Chemistry (2025) Vol. 293, pp. 117705-117705
Closed Access

Tackling neurodegeneration in vitro with omics: a path towards new targets and drugs
Caterina Carraro, Jessica V. Montgomery, Julien Klimmt, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 2

Lycopodium alkaloids from Huperzia serrata and their cholinesterase inhibitory activities
Shuai Jiang, Beibei Gao, Yu‐Fei Ou, et al.
Phytochemistry (2024) Vol. 223, pp. 114114-114114
Closed Access | Times Cited: 1

Natural compounds for Alzheimer's prevention and treatment: Integrating SELFormer-based computational screening with experimental validation
Junyu Zhou, Y. KIM, Chen Li, et al.
Computers in Biology and Medicine (2024) Vol. 185, pp. 109523-109523
Closed Access | Times Cited: 1

Design, synthesis and evaluation of imidazo[1,2-a]pyrazin-8(7H)-one derivatives as acetylcholinesterase inhibitors and antioxidants
Wen-Rong Du, Ben-Ben Wei, Xin-Yuan Guo, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 10, pp. 1938-1953
Open Access

Page 1

Scroll to top